MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY
Clinical trials for MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY trials appear
Sign up with your email to follow new studies for MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare disorder: testing drug to prevent dangerous blood sugar drops
Disease control Recruiting nowThis study is testing if a medication called triheptanoin is safe and can help prevent low blood sugar (hypoglycemia) in people aged 4 and older with Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD), a rare inherited metabolic disorder. Researchers will monitor participants…
Matched conditions: MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test how special fats affect rare metabolic disorder
Knowledge-focused Recruiting nowThis study aims to understand how different types of dietary fats affect the body's metabolism in people with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD), a rare inherited metabolic disorder. Researchers will compare 15 MCADD patients with 15 healthy individuals, havin…
Matched conditions: MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY
Phase: NA • Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC